Our preliminary in vivo siRNA study analyzing whole-body metabolic function suggest the possibility that the hepatokine INHBE decreases fat utilization and increases fat mass in the mice model of obesity. Here, INHBE is linked to obesity due to melanocortin 4 receptor deficiency.